Hikma Pharmaceuticals Plc Holding(s) in Company (1308R)
25 Giugno 2020 - 05:12PM
UK Regulatory
TIDMHIK
RNS Number : 1308R
Hikma Pharmaceuticals Plc
25 June 2020
TR-1: S tandard form for notification of major holdings
LONDON, 25 June 2020 - Hikma Pharmaceuticals PLC (LEI:
549300BNS685UXH4JI75) (LSE: HIK) (NasdaqDubai: HIK) (LSE: HIK)
announces as follows:
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the Hikma Pharmaceuticals PLC (LEI: 549300BNS685UXH4JI75)
underlying issuer of existing shares
to which voting rights are attached
(ii) :
--------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify)(iii) :
----
3. Details of person subject to the notification obligation (iv)
Name Boehringer Ingelheim Invest GmbH
City and country of registered office Ingelheim am Rhein, Germany
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name N/A
--------------------------------------------------------
City and country of registered office N/A
(if applicable)
--------------------------------------------------------
5. Date on which the threshold was 23 June 2020
crossed or reached (vi) :
25 June 2020
--------------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 25 June 2020
--------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
--------------------- ----------------------- -------------------- ------------------------
Resulting situation 23 June 2020: 0 23 June 2020: 23 June 2020:
on the date 12,833,233 shares 12,833,233 shares 12,833,233
on which threshold bought back bought back shares bought
was crossed by the issuer by the issuer back by the
or reached with a resultant with a resultant issuer with
position of position of a resultant
11.16%. 11.16%. position of
25 June 2020: 25 June 2020: 27,166,767.
Remaining 27,166,767 Remaining 25 June 2020:
shares sold 27,166,767 Remaining 27,166,767
in a placing shares sold shares sold
with a resultant in a placing in a placing
position of with a resultant with a resultant
0%. position of position of
0%. 0.
--------------------- ----------------------- -------------------- ------------------------
Position of
previous
notification
(if
applicable) 16.67% 0 16.67%
--------------------- ----------------------- -------------------- ------------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
--------------------------
23 June 2020:
12,833,233 shares
bought back 23 June 2020:
by the issuer 12,833,233 shares
with a resultant bought back by
position of the issuer with
27,166,767 . a resultant position
25 June 2020: of 11.16%.
Remaining 27,166,767 25 June 2020:
shares sold Remaining 27,166,767
in a placing shares sold in
Ordinary shares with a resultant a placing with
of 10 pence each position of a resultant position
(GB00B0LCW083) 0. 0 of 0%. 0
------------------------ -------------------------- ------------------------- ---------------------
SUBTOTAL 8. A 23 June 2020: 27,166,767 23 June 2020: 11.16%
25 June 2020: 0 25 June 2020: 0%
---------------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
(x) (xi) be acquired if
the instrument
is
exercised/converted.
------------ ------------------------------- -------------------------------- ---------------------
N/A
-------------------------------------------- -------------------------------- ---------------------
SUBTOTAL 8. B 1
-------------------------------------------- -------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date (x) Conversion cash voting rights rights
instrument Period (xi) settlement
(xii)
------------------ --------------------- -------------------- --------------------
N/A
--------- -------------------- --------------------
SUBTOTAL 8.B.2
-------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights X
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (xiv) (please add additional
rows as necessary)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
C.H. Boehringer
Sohn AG & Co. KG 0 0 0
---------------------- --------------------- ------------------------
Boehringer Ingelheim
Corporate Center
GmbH 0 0 0
---------------------- --------------------- ------------------------
Boehringer Ingelheim
Verwaltungs GmbH 0 0 0
---------------------- --------------------- ------------------------
Boehringer Ingelheim
International GmbH 0 0 0
---------------------- --------------------- ------------------------
Boehringer Ingelheim
Auslandsbeteiligungs
GmbH 0 0 0
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder N/A
-----------------------------------------------
The number and % of voting rights N/A
held
-----------------------------------------------
The date until which the voting rights N/A
will be held
-----------------------------------------------
11. Additional information (xvi)
None
Place of completion Germany
Date of completion Buyback by the issuer completed 23 June 2020.
Sale in the placing completed 25 June 2020.
----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLUVAVRRRUNUAR
(END) Dow Jones Newswires
June 25, 2020 11:12 ET (15:12 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2023 a Mar 2024